AI-complemented Mechanism Agnostic Targeted Therapies across Indications

News

News & Events

Recent highlights on our programs, News, Events and Leadership

Image for Satya Pharma Innovations Granted DSIR Recognition for R&D Excellence

March 28, 2025

Satya Pharma Innovations Granted DSIR Recognition for R&D Excellence

Read More
Image for Satya announces discovery of best-in-class, selective PKMYT1 inhibitor in collaboration with US/ Japanese biotech Alivexis, Inc.

November 21, 2024

Satya announces discovery of best-in-class, selective PKMYT1 inhibitor in collaboration with US/ Japanese biotech Alivexis, Inc.

Read More
Image for Satya attending ASCO 2024 in Chicago (May 31st – June 4th, 2024)

May 14, 2024

Satya attending ASCO 2024 in Chicago (May 31st – June 4th, 2024)

Read More
Image for Satya to present preclinical profile of its PARG inhibitors at the 2024 American Association for Cancer Research (AACR) Annual Meeting – April 5-10, San Diego, CA

March 21, 2024

Satya to present preclinical profile of its PARG inhibitors at the 2024 American Association for Cancer Research (AACR) Annual Meeting – April 5-10, San Diego, CA

Read More
Image for Satya @ JPM 2024

January 18, 2024

Satya @ JPM 2024

Read More
Image for Satya to present the preclinical profile of first-in-class RAD51 inhibitors at the Upcoming ESMO Congress – Oct 20-24, Madrid, Spain

September 28, 2023

Satya to present the preclinical profile of first-in-class RAD51 inhibitors at the Upcoming ESMO Congress – Oct 20-24, Madrid, Spain

Read More
Image for Satya to Highlight its SOS1 inhibitors that demonstrate best-in-class single agent activity in preclinical models of KRAS driven tumors at the Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Oct 11-15, Boston, USA

September 26, 2023

Satya to Highlight its SOS1 inhibitors that demonstrate best-in-class single agent activity in preclinical models of KRAS driven tumors at the Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Oct 11-15, Boston, USA

Read More
Image for Satya to present preclinical profile of its KIF18A inhibitors at the Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Oct 11-15, Boston, USA

September 25, 2023

Satya to present preclinical profile of its KIF18A inhibitors at the Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Oct 11-15, Boston, USA

Read More
Image for Satya is at BIO, 2023 – Boston, June 3-6

June 2, 2023

Satya is at BIO, 2023 – Boston, June 3-6

Read More
Image for Satya chosen as one of the top Promising startups at BIO ASIA 2023

February 26, 2023

Satya chosen as one of the top Promising startups at BIO ASIA 2023

Read More
Image for Satya is at JPM, 2023

January 5, 2023

Satya is at JPM, 2023

Read More
Image for Satutory Form 5A

August 20, 2022

Satutory Form 5A

Read More

Go Back Top